In one analysis referencing both the WHO and Stanford classifications, atypical leiomyoma, STUMP, and leiomyosarcoma demonstrated significantly higher frequencies of TP53 mutations and PTEN deletions than conventional leiomyoma and leiomyoma variants. The gene discussed is TP53; the disease is leiomyosarcoma.